438 results on '"Barbaud A"'
Search Results
2. Efficient and stable tin perovskite solar cells enabled by amorphous-polycrystalline structure.
- Author
-
Liu, Xiao, Wang, Yanbo, Wu, Tianhao, He, Xin, Meng, Xiangyue, Barbaud, Julien, Chen, Han, Segawa, Hiroshi, Yang, Xudong, and Han, Liyuan
- Subjects
SOLAR cells ,SOLAR cell efficiency ,LEAD ,TIN - Abstract
Tin perovskite solar cells (TPSCs) have triggered intensive research as a promising candidate for lead-free perovskite solar cells. However, it is still challenging to obtain efficient and stable TPSCs because of the low defects formation energy and the oxidation of bivalent tin; Here, we report a TPSC with a stable amorphous-polycrystalline structure, which is composed of a tin triple-halide amorphous layer and cesium-formamidinium tin iodide polycrystals. This structure effectively blocks the outside oxygen, moisture and also suppresses the ion diffusion inside the devices. In addition, its energy level benefits the charge extraction and transport in TPSCs. This design enabled us to obtain the certified quasi-steady-state efficiency over 10% for TPSCs from an accredited certification institute. The cell was stable, maintaining 95% of the initial PCE after operation at the maximum power point under AM 1.5 G simulated solar light (100 mWcm
−2 ) for 1000 hours. Tin based perovskite solar cells could be promising replacements for lead based counterparts due to their lower toxicity, but their efficiencies are much lower. Here, Liu et al. report stable tin based perovskite solar cells with efficiency over 10% by designing amorphous-polycrystalline nanostructures. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
3. Skin Testing and Patch Testing in Non-IgE-Mediated Drug Allergy.
- Author
-
Barbaud, Annick
- Abstract
Drug skin tests can reproduce delayed hypersensitivity to drugs and entail a moderate reexposure of patients to offending drugs. Drug patch tests (DPTs) and prick tests can be done with any commercialized form of a drug. In non-severe delayed non-IgE-mediated reactions to drugs, intradermal tests (IDT) with delayed readings have a greater value, but their techniques lack standardization. A negative drug skin test does not exclude the responsibility of a drug, and the drug must be rechallenged in non-severe cases. DPTs are useful in maculopapular rashes, flexural exanthemas, and if done in situ, also in fixed drug eruption. Their best indication is in acute generalized exanthematous pustulosis or drug reaction with eosinophilia and systemic symptoms (DRESS). They should be carried out cautiously, following strict guidelines. Prick tests have a low value but they can sometimes be positive on delayed readings. In non-severe delayed reactions to drugs, intradermal tests with delayed readings are the most sensitive skin tests especially for beta-lactam antibiotics, radiocontrast media, heparins but also some biological agents. The value of patch testing varies according to the implicated drug and the non-immediate adverse drug reaction. In DRESS, DPTs have a good value in testing carbamazepine or proton pump inhibitors but remain negative in testing with allopurinol or salazopyrin. In toxic epidermal necrolysis, DPTs are safe but positive in only 9 to 23 % of the reported cases. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
4. Systemic sclerosis is associated with lower limb vascular stiffness and microvascular impairment: results from a prospective study.
- Author
-
Cassius, Charles, Seta, Vannina, Monfort, Jean-Benoit, Baudot, Nathalie Abdoucheli, Rivière, Sébastien, Mekinian, Arsène, Frances, Camille, Barbaud, Annick, and Senet, Patricia
- Subjects
SYSTEMIC scleroderma ,DUPLEX ultrasonography ,PERIPHERAL vascular diseases ,CONNECTIVE tissue diseases ,ANKLE brachial index - Abstract
Objective: Systemic sclerosis (SSc) is a connective tissue disease characterized by microangiopathy. Peripheral arterial disease, increasingly studied during SSc, is responsible for digital ulcers, associated with a high risk of amputation. The aim of our study was to assess the frequency of lower limb arterial impairment in SSc patients by measuring ankle-brachial index (ABI), toe pressure (TP), and toe-brachial index (TBI). Methods: Systemic sclerosis patients were included prospectively during 1 year in Tenon and Saint-Antoine Hospitals, Paris. Clinical and biological data were recorded. For each patient, ABI, TP, and TBI were measured and an arterial duplex ultrasonography was prescribed in case of abnormal results. Results: Eighty-six patients were included (94% women, median age 62 years). Only 24% of them had no lower limb hemodynamic vascular abnormalities; 44% had an isolated microvascular abnormality (normal ABI and TBI<0.75); 31% had at least a macrovascular injury associated or not with microvascular impairment (abnormal ABI) and 12.6% had a TP<50 mmHg. During follow-up, there was a trend towards association of low TBI with more major adverse event (all-cause mortality, non-fatal stroke, non-fatal myocardial infarction, and lower limb ischemic manifestations) than normal TBI. Conclusion: By measuring ABI and TP, we showed that 76% of SSc patients had hemodynamic arterial lower limb abnormalities related to macro- and/or microvascular impairment and that 28% had vascular stiffness. In SSc patients, ABI is not an accurate tool to detect lower limb arterial disease, likely due to underlying micro- and macrovascular changes. Key Points • The presence of lower limb macro-and/or microvascular involvement was detected in 76% of SSc patients. • In SSc patients, ABI is not an accurate tool to detect lower limb arterial disease, likely due to underlying microvascular changes and frequent arterial stiffness. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
5. Cumulative Incidence of, Risk Factors for, and Outcome of Dermatological Complications of Anti-TNF Therapy in Inflammatory Bowel Disease: A 14-Year Experience.
- Author
-
Fréling, Estelle, Baumann, Cédric, Cuny, Jean-François, Bigard, Marc-André, Schmutz, Jean-Luc, Barbaud, Annick, and Peyrin-Biroulet, Laurent
- Subjects
INFLAMMATORY bowel diseases ,ULCERATIVE colitis ,DRUG side effects ,DISEASE incidence ,PSORIASIS ,PROPORTIONAL hazards models ,PATIENTS - Abstract
Objectives:The broader and prolonged use of anti-tumor necrosis factor (TNF) agents in inflammatory bowel disease (IBD) could expose patients to an increased risk of adverse reactions, including dermatological complications. We assessed the cumulative incidence of anti-TNF-induced cutaneous adverse reactions in IBD patients, their risk factors, their dermatological management, and their outcome in a large cohort of IBD patients.Methods:In a single-center observational retrospective study, including all consecutive adult IBD patients treated with an anti-TNF agent between 2001 and 2014, all patients with dermatological complications under anti-TNF therapy were identified in a well-defined cohort of IBD patients. We conducted a survival analysis to determine the cumulative incidence of dermatological complications and risk factors for developing any dermatological complications, cutaneous infections, and psoriasiform lesions. Survival curves were estimated by the Kaplan-Meier method, and we used a Cox proportional hazards model to test the association between parameters and time to each event: any dermatological complication, cutaneous infections, and psoriasis lesions.Results:Among 583 IBD patients, 176 dermatological complications occurred, involving 20.5% of patients. Median duration of follow-up was 38.2 months (range: 1-179). Psoriasiform lesions (10.1%; 59/583) and cutaneous infections (11.6%, 68/583) were the most frequently observed, with a cumulative incidence of, respectively, 28.9% and 17.6% at 10 years. They led to anti-TNF discontinuation, respectively, in 18.6% and 2.9% of patients. In case of switching to another anti-TNF agent for psoriasiform lesions, recurrence occurred in 57% of patients. Ulcerative colitis was associated with a lower risk of developing cutaneous infections than Crohn's disease (hazard ratio (HR)=0.25; 95% confidence interval (CI)=0.09-0.68; P=0.007). Higher dosing of anti-TNF agent was associated with a higher risk of developing cutaneous infections (HR=1.99; 95% CI=1.09-3.64; P=0.025). A younger age at time of anti-TNF initiation was associated with a higher risk of dermatological complications (HR=2.25; 95% CI=1.39-3.62; P<0.001).Conclusions:Dermatological complications involve one of five patients treated with anti-TNF therapy after a 14-year follow-up. Association of cutaneous infections with higher anti-TNF dosing suggests a dose-dependent effect. Discontinuation of anti-TNF therapy due to dermatological complications is required in one out of five patients with psoriasiform lesions, but specific dermatological treatment allows to continue anti-TNF therapy in half of them. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
6. The use of three-dimensional similarity in assessing the risk of cross-reactivity between carbamazepine and psychotropic drugs.
- Author
-
Louarn, Eric, Barbaud, Annick, Trechot, Philippe, Marcou, Gilles, and Lepoittevin, Jean-Pierre
- Subjects
CARBAMAZEPINE ,PHARMACEUTICAL chemistry ,PSYCHIATRIC drugs ,THREE-dimensional imaging ,DATA analysis software ,PHARMACODYNAMICS - Abstract
The article discusses research which was conducted to measure the three dimensional similarity between carbamazepine and 40 psychotropic drugs with similar or adjacent indications. After evaluating the drugs the researchers concluded that their research results were not sufficient for clinical decision making in patients sensitized to carbamazepine and that the results should be considered as one line of evidence among others for benefit-risk assessment.
- Published
- 2014
- Full Text
- View/download PDF
7. Place of excipients in drug-related allergy.
- Author
-
Barbaud, Annick
- Published
- 1995
- Full Text
- View/download PDF
8. Fluindione and drug reaction with eosinophilia and systemic symptoms: an unrecognised adverse effect?
- Author
-
Daveluy, Amélie, Milpied, Brigitte, Barbaud, Annick, Lebrun-Vignes, Bénédicte, Gouraud, Aurore, Laroche, Marie-Laure, Ciobanu, Ecaterina, Bégaud, Bernard, Moore, Nicholas, Miremont-Salamé, Ghada, and Haramburu, Françoise
- Subjects
ANTICOAGULANTS ,DATABASES ,DRUG allergy ,DRUG eruptions ,DRUG side effects ,EOSINOPHILIA ,HEALTH outcome assessment ,VITAMIN K ,TREATMENT effectiveness ,CHEMICAL inhibitors - Abstract
Purpose: Fluindione is an oral vitamin K antagonist (indanedione derivative) exclusively marketed in France and Luxembourg, known to have immuno-allergic adverse effects such as hepatitis, fever or interstitial nephritis. A few cases of drug reaction with eosinophilia and systemic symptoms (DRESS) have been reported with fluindione. The aim of the present study was to investigate fluindione-induced DRESS cases reported in France and to describe their characteristics. Methods: We searched for potential cases of DRESS with fluindione reported in the French pharmacovigilance database since 2000. Results: Thirty-six cases of DRESS were included and concerned 17 women and 19 men. The mean age was 65 years (median: 68 years, range: 28-95 years). Kidneys and liver were the most frequent organs involved. Thirty-five cases were serious. In 5 cases, the effect was life-threatening. Most of the patients recovered. Fluindione was the only medicine suspected in 26 cases. Skin patch tests, performed in 10 cases, were positive with fluindione in 9 cases. Conclusions: Fluindione is not known to be a frequent cause of DRESS. However, the number of reports found is probably underestimated. The seriousness of DRESS, as all immuno-allergic adverse effects, contraindicates fluindione reintroduction. Coumarinic derivatives are the alternatives in patients who need oral anticoagulant treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
9. New amphiphilic graft copolymer based on poly(ß-malic acid): synthesis and characterization.
- Author
-
Olivier Coulembier, Philippe Degée, Christel Barbaud, Philippe Guérin, and Philippe Dubois
- Published
- 2004
10. Fertility Signaling and Partitioning of Reproduction in the Ant Neoponera apicalis.
- Author
-
Yagound, Boris, Gouttefarde, Rémi, Leroy, Chloé, Belibel, Rima, Barbaud, Christel, Fresneau, Dominique, Chameron, Stéphane, Poteaux, Chantal, and Châline, Nicolas
- Subjects
INSECT societies ,PACHYCONDYLA ,INSECT fertility ,CELLULAR signal transduction ,BIOLOGICAL assay ,REPRODUCTION ,INSECTS - Abstract
All individuals in social insect colonies benefit from being informed about the presence and fertility state of reproducers. This allows the established reproductive individuals to maintain their reproductive monopoly without the need for physical control, and the non-reproductive individuals to make appropriate reproductive choices. Here, we studied whether fertility signaling is responsible for the partitioning of reproduction in the ant Neoponera apicalis. This species forms small colonies from one single-mated queen, with workers establishing reproductive hierarchies when hopelessly queenless. Previous studies identified putative fertility signals, particularly the hydrocarbon 13-methylpentacosane (13-MeC), and have shown that precise status discrimination based on these signals could be involved in the regulation of reproductive activities. Here, we extend these findings and reveal that all individuals, be they queens or workers, differ in their cuticular hydrocarbon profile according to fertility state. Proportions of 13-MeC were a strong predictor of an individual's ovarian activity, and could, thus, advertise the established reproducer(s) in both queenright and queenless conditions. Furthermore, this compound might play a key role in the establishment of the reproductive hierarchy, since workers with low fertility at the onset of hierarchy formation already have relatively high amounts of 13-MeC. Dyadic encounters showed that individuals with experimentally increased amounts of 13-MeC triggered less agonistic interactions from top rankers, in accord with them 'advertising' higher status. Thus, these bioassays supported the use of 13-MeC by competing ants. This simple recognition system potentially allows permanent regulation of partitioning of reproduction in this species. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
11. Poly(β-malic acid) derivatives with non-charged hydrophilic lateral groups: synthesis and characterization.
- Author
-
Barbaud, Christel, Cammas-Marion, Sandrine, and Guérin, Philippe
- Abstract
Poly((3-hydroxypropyl β malate) has been synthesized starting from aspartic acid and benzyloxy-1-propanol as precursors. This new polymer was characterized by
1 H and13 C NMR, size exclusion chromatography and differential scanning calorimetry. Homopolymer is soluble in water. Two kinds of amphiphilic copolymers were also prepared and characterized. Such polymers have been synthesized with a view to preparing non-charged degradable associating networks or drug carriers. [ABSTRACT FROM AUTHOR]- Published
- 1999
- Full Text
- View/download PDF
12. Assessment of a fast challenge test with iodinated contrast media in allergic patients with anaphylaxis.
- Author
-
Vega, Francisco, Lopez-Raigada, Azahara, Mugica, M. Victoria, Jimenez-Saiz, Rodrigo, and Blanco, Carlos
- Published
- 2024
- Full Text
- View/download PDF
13. Causative agent for perioperative anaphylaxis in a child with autism successfully identified using the intradermal test under general anesthesia.
- Author
-
Amano, Yasuhiro, Mizutani, Kumi, Kato, Yuki, Fujii, Tasuku, Yagami, Akiko, and Tamura, Takahiro
- Subjects
INTRADERMAL injections ,AUTISTIC children ,LIP surgery ,PALATE surgery ,AUTISM in children - Abstract
Background: The skin-prick and intradermal tests are the main diagnostic methods used to identify the causative agent in patients with suspected perioperative anaphylaxis. Although the intradermal test is more sensitive than the skin-prick test, multiple intradermal injections can be painful for children. Here, we present the case of a child with autism and suspected perioperative anaphylaxis. The causative agent was successfully identified using the intradermal test under general anesthesia. Case presentation: An 8-year-old boy with autism developed anaphylaxis during general anesthesia for the fourth cleft lip and palate surgery. An allergic workout was performed, but both the skin-prick and basophil activation tests for suspected causative agents yielded negative results. The patient was afraid of multiple injections, and an intradermal test was performed under general anesthesia by anesthesiologists and allergists. Piperacillin was confirmed as the causative agent, and subsequent surgery using the same anesthetic agents without piperacillin was uneventful. Conclusions: Concerted efforts should be made to identify the causative agent for diagnosing perioperative anaphylaxis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. 7th Drug hypersensitivity meeting: part two
- Author
-
Javier Dionicio Elera, Cosmin Boteanu, Maria Aranzazu Jimenez Blanco, Rosario Gonzalez-Mendiola, Irene Carrasco García, Antonio Alvarez, Jose Julio Laguna Martinez, Jaume Martí Garrido, Carla Torán Barona, Carolina Perales Chorda, Ramón López Salgueiro, Miguel Díaz Palacios, Dolores Hernández Fernández De Rojas, Emre Ali Acar, Ayse Aktas, Aylin Türel Ermertcan, Peyker Temiz, Chien-Yio Lin, Chung-Yee Rosaline Hui, Ya-Ching Chang, Chih-Hsun Yang, Wen-Hung Chung, Fabrícia Carolino, Diana Silva, Eunice Dias De Castro, Josefina R. Cernadas, Luis Felipe Ensina, Carolina Aranda, Ines Camelo Nunes, Alex Lacerda, Ana Maria Martins, Ekaterini Goudouris, Marcia Ribeiro, José Francisco Da Silva Franco, Leandra Queiroz, Dirceu Solé, Ceyda Tunakan Dalgiç, Aytül Zerrin Sin, Fatma Düsünür Günsen, Gökten Bulut, Fatma Ömür Ardeniz, Okan Gülbahar, Emine Nihal Mete Gökmen, Ali Kokuludag, Ana M. Montoro De Francisco, Talía Mª De Vicente Jiménez, Adriana M. Mendoza Parra, Angella M. Burgos Pimentel, Amelia García Luque, Luis Amaral, Leonor Carneiro Leão, Nicole Pinto, Joana Belo, João Marques, Pedro Carreiro-Martins, Paula Leiria-Pinto, Amel Chaabane, Haifa Ben Romdhane, Nadia Ben Fredj, Zohra Chadly, Naceur A. Boughattas, Karim Aouam, Astrid P. Uyttebroek, Chris H. Bridts, Antonino Romano, Didier G. Ebo, Vito Sabato, Anabela Lopes, Joana Cosme, Rita Aguiar, Tatiana Lourenço, Maria-João Paes, Amélia Spínola-Santos, Manuel Pereira-Barbosa, Cíntia Rito Cruz, Rute Pereira Dos Reis, Elza Tomaz, Ana Paula Pires, Filipe Inácio, Filipe Benito-Garcia, Inês Mota, Magna Correia, Ângela Gaspar, Marta Chambel, Susana Piedade, Mário Morais-Almeida, Alla Nakonechna, Yurij Antipkin, Tetiana Umanets, Fernando Pineda, Francisca Arribas, Volodymyr Lapshyn, Pablo Andrés Miranda, Bautista De La Cruz Hoyos, Aranzazu Jimenez Blanco, Marta Del Pozo, Alessandra Vultaggio, Francesca Nencini, Sara Pratesi, Andrea Matucci, Enrico Maggi, Ivana Cegec, Danica Juricic Nahal, Viktorija Erdeljic Turk, Matea Radacic Aumiler, Ksenija Makar Ausperger, Iva Kraljickovic, Iveta Simic, Yukie Yamaguchi, Tomoya Watanabe, Megumi Satoh, Tomohiko Tanegashima, Kayoko Oda, Hidefumi Wada, Michiko Aihara, Jaechun Jason Lee, Jay Chol Choi, Hwa Young Lee, Rosa-Anita Rodrigues Fernandes, Emília Faria, Joana Pita, Nuno Sousa, Carmelita Ribeiro, Isabel Carrapatoso, Ana Todo Bom, Ana Rodolfo, Eunice Dias-Castro, Marina Voronova, Diana Kury Valle, Verónica Pacheco Coronel, Carolina Perales Chordá, Roselle Catherine Yu Madamba, Marta Ferrer, Maria Jose Goikoetxea, Carmen D’Amelio, Amalia Bernad, Olga Vega, Gabriel Gastaminza, Beatriz Pola Bibián, Marina Lluncor Salazar, Gemma Vilà-Nadal, Ana María Fiandor Roman, Javier Dominguez Ortega, Miguel Gonzalez Muñoz, Santiago Quirce Gancedo, Maria Rosario Cabañas Moreno, Kathrin Scherer Hofmeier, Vladyslava Barzylovych, Beatriz Pola, Marina Lluncor, Ana Fiandor, Teresa Bellón, Javier Domínguez, Santiago Quirce, Min-Suk Yang, Sun-Sin Kim, Sae-Hoon Kim, Hye-Ryun Kang, Heung-Woo Park, Sang-Heon Cho, Kyung-Up Min, Yoon-Seok Chang, Clémence Delahaye, Jenny Flabbee, Julie Waton, Olivia Bauvin, Annick Barbaud, Najah Ben Fadhel, Sandra Jerkovic Gulin, Anca Chiriac, Bárbara Kong Cardoso, Regina Viseu, Ana Moreira, Susana Cadinha, Ana Castro Neves, Patrícia Barreira, Daniela Malheiro, J. P. Moreira Da Silva, Ružica Jurakic-Toncic, Suzana Ljubojevic, Petra Turcic, Liesbeth Gilissen, Sara Huygens, An Goossens, Inmaculada Andreu, Alicia Martinez Romero, Pau Gomez Cabezas, Pedro Ayuso Parejo, Maria Del Carmen Plaza-Serón, Inmaculada Doña, Natalia Blanca-López, Carlos Flores, María Luisa Galindo, Ana Molina, James Richard Perkins, José Antonio Cornejo-García, José Augusto García-Agúndez, Elena García-Martín, Paloma Campo, María Gabriela Canto, Miguel Blanca, Rosa María Guéant-Rodríguez, Raquel Jurado-Escobar, Esther Barrionuevo, María Salas, Gabriela Canto, Jean-Louis Guéant, Toru Usui, Arun Tailor, Lee Faulkner, John Farrell, Ana Alfirevic, B. Kevin Park, Dean J. Naisbitt, Oswaldo Trelles, María Auxiliadora Guerrero, Alex Upton, Mayumi Ueta, Hiromi Sawai, Chie Sotozono, Katushi Tokunaga, Shigeru Kinoshita, Chonlaphat Sukasem, Patompong Satapornpong, Therdpong Tempark, Pawinee Rerknimitr, Kulprapat Pairayayutakul, Jettanong Klaewsongkram, N. Koomdee, T. Jantararoungtong, S. Santon, A. Puangpetch, U. Intusoma, W. Tassaneeyakul, V. Theeramoke, Elena Ramirez, Alberto Manuel Borobia, Hoi Tong, Jose Luis Castañer, Francisco José De Abajo, Violeta Régnier Galvao, Rebecca Pavlos, Elizabeth Mckinnon, Kristina Williams, Alicia Beeghly-Fadiel, Alec Redwood, Elizabeth Phillips, Mariana Castells, Elisa Boni, Marina Russello, Marina Mauro, Kok Loong Ue, Krzysztof Rutkowski, Victor Soriano Gomis, Jorge Frances Ferre, Angel Esteban Rodriguez, Vicente Cantó Reig, Javier Fernandez Sanchez, Christine Breynaert, Erna Van Hoeyveld, Rik Schrijvers, Raquel Fuentes Irigoyen, Daniel Collado, Yolanda Vida, Francisco Najera, Ezequiel Perez-Inestrosa, Pablo Mesa-Antunez, Cristobalina Mayorga, María José Torres, Line K. Tannert, Charlotte G. Mortz, Per Stahl Skov, Carsten Bindslev-Jensen, Wolfgang Pfützner, Hannah Dörnbach, Johanna Visse, Michele Rauber, Christian Möbs, Abdelbaset A. Elzagallaai, Lindsey Chow, Awatif M. Abuzgaia, Michael J. Rieder, Jason Trubiano, Emily Woolnough, Kaija Stautins, Christina Cheng, Kenichi Kato, Hiroaki Azukizawa, Takaaki Hanafusa, Ichiro Katayama, Toshiharu Fujiyama, Hideo Hashizume, Takatsune Umayahara, Taisuke Ito, Yoshiki Tokura, Mira Silar, Mihaela Zidarn, Helena Rupnik, Peter Korosec, Alec James Redwood, Kaija Strautins, Katie White, Abha Chopra, Katherine Konvinse, Shay Leary, Simon Mallal, Rosario Cabañas, Ana María Fiandor, Andrew Sullivan, Paul Whitaker, Daniel Peckham, Wei Yann Haw, Marta E. Polak, Carolann Mcguire, Michael R. Ardern-Jones, Yumi Aoyama, Tetsuo Shiohara, Sara Correia, Asli Gelincik, Semra Demir, Fatma Sen, Hamza Ugur Bozbey, Muge Olgac, Derya Unal, Raif Coskun, Bahauddin Colakoglu, Suna Buyuozturk, Esin Çatin-Aktas, Gunnur Deniz, Jose Julio Laguna, J. Dionicio, Tahia Fernandez, I. Olazabal, Maria Dolores Ruiz, Maria José Torres, Alberto Lafuente, Jorge Núñez, Tahia Diana Fernández, Francisca Palomares, Rubén Fernández, Maria Isabel Sanchez, Tahía Fernandez, Arturo Ruiz, Adriana Ariza, Amalia Bernad Alonso, Carmen D’Amelio Garófalo, Olga Vega Matute, Marta Ferrer Puga, María José Goikoetxea Lapresa, Gabriel Gastaminza Lasarte, Antonia Thinnes, Hans F. Merk, Jens Malte Baron, Martin Leverkus, Galina Balakirski, Andrew Gibson, Monday Ogese, Zaid Al-Attar, Fiazia Yaseen, Xiaoli Meng, Rozalind Jenkins, John Farrel, Khetam Alhilali, Yanni Xue, Patricia Illing, Nicole Mifsud, Heidi Fettke, Jeffrey Lai, Rebecca Ho, Patrick Kwan, Anthony Purcell, Monday O. Ogese, Catherine Betts, Paul Thomson, Mohammad Alhaidari, Neill Berry, Paul M. O’Neill, Abdulaziz Alzahrani, Marie Eliane Azoury, Lucia Fili, Rami Bechara, Noémie Scornet, Cathy Nhim, Richard Weaver, Nancy Claude, Delphine Joseph, Bernard Maillere, Paola Parronchi, Marc Pallardy, Axel Patrice Villani, Aurore Rozières, Benoît Bensaïd, Mathilde Tardieu, Floriane Albert, Virginie Mutez, Tugba Baysal, Janet Maryanski, Jean-François Nicolas, Osami Kanagawa, Marc Vocanson, Shuen-Iu Hung, Caroline J. Harrison, Rosalind E. Jenkins, Neil S. French, Maria Isabel Montañez, Tahia D. Fernandez, Angela Martin-Serrano, Maria Jose Torres, Noemi Molina, Sally Wood, Munir Pirmohamed, María Isabel Montañez, Ángela Martín-Serrano, Ezequiel Pérez-Inestrosa, Dolores Pérez-Sala, Antonio E. Guzmán, Tai-Ming Ko, Yuan-Tsong Chen, Jer-Yuarn Wu, Francisco J. Sánchez-Gómez, Juan M. González-Morena, María J. Torres, Alejandra Monroy Arreola, Jesus Agustin Badillo Corona, Silvia Mendez Flores, Judith Dominguez Cherit, Noe Valentin Duran Figueroa, Jose Luis Castrejon Flores, James Perkins, Diana Pérez-Alzate, Gador Bogas, María J Torres, Luis Mario Tubella Marti, Fernando Pineda De La Losa, Francisca Arribas Poves, Jaime Tubella Lopez, and Teodora Lopez Santiago
- Subjects
Pulmonary and Respiratory Medicine ,Immunology ,Immunology and Allergy ,Meeting Abstracts - Abstract
Table of contents Poster walk 11: miscellaneous drug hypersensitivity 2 (P92–P94, P96–P101) P92 16 years of experience with proton pump inhibitors (PPIs) Javier Dionicio Elera, Cosmin Boteanu, Maria Aranzazu Jimenez Blanco, Rosario Gonzalez-Mendiola, Irene Carrasco García, Antonio Alvarez, Jose Julio Laguna Martinez P93 Allergy evaluation of quinolone induced adverse reactions Jaume Martí Garrido, Carla Torán Barona, Carolina Perales Chorda, Ramón López Salgueiro, Miguel Díaz Palacios, Dolores Hernández Fernández De Rojas P94 Bupropion-induced acute urticaria and angioedema, a case report Emre Ali Acar, Ayse Aktas, Aylin Türel Ermertcan, Peyker Temiz P96 Delayed type hypersensitivity and study of cross-reactivity between proton-pump inhibitors Chien-Yio Lin, Chung-Yee Rosaline Hui, Ya-Ching Chang, Chih-Hsun Yang, Wen-Hung Chung P97 Diagnostic work-up in suspected hypersensitivity to proton-pump inhibitors: looking at cross-reactivity Fabrícia Carolino, Diana Silva, Eunice Dias De Castro, Josefina R. Cernadas P98 Management of infusion-related hypersensitivity reactions to enzyme replacement therapy for lysosomal diseases Luis Felipe Ensina, Carolina Aranda, Ines Camelo Nunes, Alex Lacerda, Ana Maria Martins, Ekaterini Goudouris, Marcia Ribeiro, José Francisco Da Silva Franco, Leandra Queiroz, Dirceu Solé P99 Management of insulin allergy with continuous subcutaneous insulin infusion Ceyda Tunakan Dalgiç, Aytül Zerrin Sin, Fatma Düsünür Günsen, Gökten Bulut, Fatma Ömür Ardeniz, Okan Gülbahar, Emine Nihal Mete Gökmen, Ali Kokuludag P100 Off-label use of icatibant for management of serious angioedema associated with angiotensin inhibitors Ana M. Montoro De Francisco, Talía Mª De Vicente Jiménez, Adriana M. Mendoza Parra, Angella M. Burgos Pimentel, Amelia García Luque P101 Thiocolchicoside anaphylaxis: an unusual suspect? Luis Amaral, Fabricia Carolino, Leonor Carneiro Leão, Eunice Castro, Josefina Cernadas Poster walk 12: betalactam hypersensitivity (P102–P111) P102 A curious delayed reading: a case report of a β-lactam allergy in a child Nicole Pinto, Joana Belo, João Marques, Pedro Carreiro-Martins, Paula Leiria-Pinto P103 Betalactam-induced hypersensitivity: a 10-years’ experience Amel Chaabane, Haifa Ben Romdhane, Nadia Ben Fredj, Zohra Chadly, Naceur A. Boughattas, Karim Aouam P104 Cefazolin hypersensitivity: towards optimized diagnosis Astrid P. Uyttebroek, Chris H. Bridts, Antonino Romano, Didier G. Ebo, Vito Sabato P105 Clavulanic acid allergy: two cases report Anabela Lopes, Joana Cosme, Rita Aguiar, Tatiana Lourenço, Maria-João Paes, Amélia Spínola-Santos, Manuel Pereira-Barbosa P106 Diagnosis of betalactam allergy in an allergy department Cíntia Rito Cruz, Rute Pereira Dos Reis, Elza Tomaz, Ana Paula Pires, Filipe Inácio P107 Diagnostic work-up of 410 patients with suspicion of betalactam antibiotic hypersensitivity Filipe Benito-Garcia, Inês Mota, Magna Correia, Ângela Gaspar, Marta Chambel, Susana Piedade, Mário Morais-Almeida P108 Immediate selective hypersensitivity reactions to clavulanic acid Alla Nakonechna, Yurij Antipkin, Tetiana Umanets, Fernando Pineda, Francisca Arribas, Volodymyr Lapshyn P109 Prevalence and incidence of penicillin hypersensitivity reactions in Colombia Pablo Andrés Miranda, Bautista De La Cruz Hoyos P110 Selective sensitization to amoxicilin and clavulanic acid Jose Julio Laguna Martinez, Aranzazu Jimenez Blanco, Javier Dionicio Elera, Cosmin Boteanu, Rosario Gonzalez-Mendiola, Marta Del Pozo P111 Infliximab-specific T cells are detectable also in treated patients who have not developed anti-drug antibodies Alessandra Vultaggio, Francesca Nencini, Sara Pratesi, Andrea Matucci, Enrico Maggi Poster walk 13: biologicals, local anesthetics, others (P112–P118) P112 A case report of allergic immediate systemic reaction to adalimumab and certolizumab Ceyda Tunakan Dalgiç, Fatma Düsünür Günsen, Gökten Bulut, Fatma Ömür Ardeniz, Okan Gülbahar, Emine Nihal Mete Gökmen, Aytül Zerrin Sin, Ali Kokuludag P113 Allergy to local anesthetics: negative predictive value of skin tests Ivana Cegec, Danica Juricic Nahal, Viktorija Erdeljic Turk, Matea Radacic Aumiler, Ksenija Makar Ausperger, Iva Kraljickovic, Iveta Simic P114 Cutaneous adverse reactions of molecular targeted agents: a retrospective analysis in 150 patients in our department Yukie Yamaguchi, Tomoya Watanabe, Megumi Satoh, Tomohiko Tanegashima, Kayoko Oda, Hidefumi Wada, Michiko Aihara P115 Generalized paralysis induced by local lidocaine injection Jaechun Jason Lee, Jay Chol Choi, Hwa Young Lee P116 Hypersensitivity to local anaesthetics: a 10 year review Rosa-Anita Rodrigues Fernandes, Emília Faria, Joana Pita, Nuno Sousa, Carmelita Ribeiro, Isabel Carrapatoso, Ana Todo Bom P117 Local anaesthetics: a rare culprit in hypersensitivity reactions Ana Rodolfo, Eunice Dias-Castro, Josefina Cernadas P118 Stevens–Johnson syndrome in clinical practice: a variant of clinical course Marina Voronova Poster walk 14: RCM (P119–P128) P119 13 cases of severe anaphylactic reactions due to radiocontrast media Jaume Martí Garrido, Ramon Lopez Salgueiro, Diana Kury Valle, Verónica Pacheco Coronel, Carolina Perales Chordá, Dolores Hernandez Fernandez De Rojas P120 Anaphylactic shock after administration of iodinated contrast medium during cardiac catheterization Roselle Catherine Yu Madamba, Marta Ferrer, Maria Jose Goikoetxea, Carmen D’Amelio, Amalia Bernad, Olga Vega, Gabriel Gastaminza P121 Anaphylactic shock and cardiac arrest induced by gadolinium-based contrast agents Beatriz Pola Bibián, Marina Lluncor Salazar, Gemma Vilà Nadal, Ana María Fiandor Roman, Javier Dominguez Ortega, Miguel Gonzalez Muñoz, Santiago Quirce Gancedo, Maria Rosario Cabañas Moreno P122 Anaphylaxis to gadobenate and cross-reactivity to other gadolinium-based contrast agents in two patients Kathrin Scherer Hofmeier P123 Anaphylaxis to glatiramer acetate in a patient with multiple sclerosis Fabrícia Carolino, Vladyslava Barzylovych, Josefina R. Cernadas P124 Delayed hypersensitivity reaction to radiocontrast media Fabrícia Carolino, Diana Silva, Leonor Leão, Josefina R. Cernadas P125 Drug reaction with eosinophilia and systemic symptoms induced by iodixanol Gemma Vilà-Nadal, Beatriz Pola, Marina Lluncor, Ana Fiandor, Teresa Bellón, Javier Domínguez, Santiago Quirce P126 Electronic consultation support system for radiocontrast media hypersensitivity changes clinician’s behavior Min-Suk Yang, Sun-Sin Kim, Sae-Hoon Kim, Hye-Ryun Kang, Heung-Woo Park, Sang-Heon Cho, Kyung-Up Min, Yoon-Seok Chang P127 Hypersensitivity reactions to iodinated contrast media: skin testing and follow-up Danica Juricic Nahal, Ivana Cegec, Viktorija Erdeljic Turk, Iva Kraljickovic, Matea Radacic Aumiler, Ksenija Makar Ausperger, Iveta Simic P128 Would iodine allergy exist? Clémence Delahaye, Jenny Flabbee, Julie Waton, Olivia Bauvin, Annick Barbaud Poster walk 15: MPE/type 4 (P129–P137) P129 Delayed hypersensitivity cutaneous reactions: a case/control study from a tunisian database Karim Aouam, Najah Ben Fadhel, Zohra Chadly, Nadia Ben Fredj, Naceur A. Boughattas, Amel Chaabane P130 Delayed hypersensitivity reactions to cephalosporins: a review of seven cases Joana Cosme, Anabela Lopes, Amélia Spínola-Santos, Manuel Pereira-Barbosa P131 Diclofenac induced allergic contact dermatitis: case series of four patients Sandra Jerkovic Gulin, Anca Chiriac P132 Late-onset maculopapular rash to irbesartan Bárbara Kong Cardoso, Elza Tomaz, Regina Viseu, Filipe Inácio P133 Nonimmediate hypersensitivity reactions to betalactams: a retrospective analysis Ana Moreira, Susana Cadinha, Ana Castro Neves, Patricia Barreira, Daniela Malheiro, J. P. Moreira Da Silva P134 Occupational airborne contact dermatitis to omeprazole Ružica Jurakic-Toncic, Suzana Ljubojevic, Petra Turcic P135 Ornidazole-induced fixed drug eruption confirmed by positive patch test on a residual pigmented lesion Liesbeth Gilissen, Sara Huygens, An Goossens P136 Repeated delayed reaction induced by amoxicillin and amoxicillin clavulanate Inmaculada Andreu, Ramon Lopez-Salgueiro, Alicia Martinez Romero, Pau Gomez Cabezas P137 Systemic photosensitivity from fenofibrate in a patient photo-sensitized to ketoprofen Liesbeth Gilissen, An Goossens Poster walk 16: HLA genetics (P138–P146) P138 A copy number variation in ALOX5 and PTGER1 is associated with nonsteroidal anti-inflammatory drugs induced urticaria and/or angioedema Pedro Ayuso Parejo, Maria Del Carmen Plaza-Serón, Inmaculada Doña, Natalia Blanca López, Carlos Flores, Luisa Galindo, Ana Molina, James Richard Perkins, Jose Antonio Cornejo-García, José Augusto García-Agúndez, Elena García-Martín, Paloma Campo, María Gabriela Canto, Miguel Blanca P139 Association of galectin-3 (LGALS3) single nucleotide polymorphisms with non-steroidal anti-inflammatory drugs-induced urticaria/angioedema José Antonio Cornejo-Garcia, Inmaculada Doña, Rosa María Guéant-Rodríguez, Natalia Blanca-López, María Carmen Plaza-Serón, Raquel Jurado-Escobar, Esther Barrionuevo, María Salas, María Luisa Galindo, Gabriela Canto, Miguel Blanca, Jean-Louis Guéant P140 Detection of T cell responses to ticlopidine using peripheral blood mononuclear cells from HLA-A*33:03+ healthy donors Toru Usui, Arun Tailor, Lee Faulkner, John Farrell, Ana Alfirevic, B. Kevin Park, Dean J. Naisbitt P141 Epistasis approaches to identify novel genes potentially involved in NSAIDs hypersensitivity James Richard Perkins, Jose Antonio Cornejo García, Oswaldo Trelles, Inmaculada Doña, Esther Barrionuevo, María Salas, María Auxiliadora Guerrero, Miguel Blanca, Alex Upton P142 Genetic predisposition of cold medicine related SJS/TEN with severe ocular complications Mayumi Ueta, Hiromi Sawai, Chie Sotozono, Katushi Tokunaga, Shigeru Kinoshita P143 HLA-B*13:01 and dapsone induced hypersensitivity in Thai population Chonlaphat Chonlaphat Sukasem, Patompong Satapornpong, Therdpong Tempark, Pawinee Rerknimitr, Kulprapat Pairayayutakul, Jettanong Klaewsongkram P144 HLA-B*15:02 alleles and lamotrigine-induced cutaneous adverse drug reactions in Thai Chonlaphat Sukasem, N. Koomdee, T. Jantararoungtong, S. Santon, A. Puangpetch, U. Intusoma, W. Tassaneeyakul, V. Theeramoke P145 HLA-B*38:01 and HLA-A*24:02 allele frequencies in Spanish patients with lamotrigine-induced SCARs Teresa Bellón, Elena Ramirez, Alberto Manuel Borobia, Hoi Tong, Jose Luis Castañer, Francisco José De Abajo P146 Overrepresentation of a class II HLA haplotype in severe hypersensitivity type I reactions to carboplatin Violeta Régnier Galvao, Rebecca Pavlos, Elizabeth Mckinnon, Kristina Williams, Alicia Beeghly-Fadiel, Alec Redwood, Elizabeth Phillips, Mariana Castells Poster walk 17: in vivo diagnosis + sIgE (P147–P154) P147 Absence of specific Ig-e against beta-lactams 9 months after an allergic reaction to amoxicillin-clavulanic acid Elisa Boni, Marina Russello, Marina Mauro P148 Drug provocation tests in suspected opioid allergy Kok Loong Ue, Krzysztof Rutkowski P149 Improvement to the specific IgE cut-off in the assess of β-lactamic allergy Victor Soriano Gomis, Jorge Frances Ferre, Angel Esteban Rodriguez, Vicente Cantó Reig, Javier Fernandez Sanchez P150 Initial false negative specific IgE to gelatin in a patient with gelatin-induced anaphylaxis Christine Breynaert, Erna Van Hoeyveld, Rik Schrijvers P151 Inmediate reactions to beta-lactam antibiotics: pattern of skin test response over the time Jose Julio Laguna Martinez, Rosario Gonzalez Mendiola, Javier Dionicio Elera, Cosmin Boteanu, Aranzazu Jimenez Blanco, Marta Del Pozo, Raquel Fuentes Irigoyen P152 New fluorescent dendrimeric antigens for the evaluation of dendritic cell maturation as a test to detect allergy reactions to amoxicillin Daniel Collado, Yolanda Vida, Francisco Najera, Ezequiel Perez-Inestrosa, Pablo Mesa-Antunez, Cristobalina Mayorga, María José Torres, Miguel Blanca P153 Positive skin test or positive specific IgE to penicillin does not predict penicillin allergy Line K. Tannert, Charlotte G. Mortz, Per Stahl Skov, Carsten Bindslev-Jensen P154 Significance of skin testing and in vitro-analysis of neuromuscular blocking agents in diagnosis of perioperative drug hypersensitivity: evaluation of a negative control population Wolfgang Pfützner, Hannah Dörnbach, Johanna Visse, Michele Rauber, Christian Möbs Poster walk 18: in vitro/ex vivo (P155–P158, P160–P164) P155 Diagnostic value of the lymphocyte toxicity assay (LTA) and the in vitro platelet toxicity assay (IPTA) for β-lactam allergy Abdelbaset A. Elzagallaai, Lindsey Chow, Awatif M. Abuzgaia, Michael J. Rieder P156 Enzyme linked immunospot assay used in the diagnosis of severe cutaneous adverse reactions to antimicrobials Alec Redwood, Jason Trubiano, Rebecca Pavlos, Emily Woolnough, Kaija Stautins, Christina Cheng, Elizabeth Phillips P157 Evaluation of in vitro diagnostic methods for identifying the culprit drugs in drug hypersensitivity Kenichi Kato, Hiroaki Azukizawa, Takaaki Hanafusa, Ichiro Katayama P158 Ex-vivo expanded skin-infiltrating T cells from severe drug eruptions are reactive with causative drugs: a possible novel method for determination of causative drugs Toshiharu Fujiyama, Hideo Hashizume, Takatsune Umayahara, Taisuke Ito, Yoshiki Tokura P160 In vitro release of IL-2, IL-5 and IL-13 in diagnosis of patients with delayed-type nickel hypersensitivity Mira Silar, Mihaela Zidarn, Helena Rupnik, Peter Korosec P161 Single cell analysis of drug responsive T cells; identification of candidate drug reactive T cell receptors in abacavir and carbamazepine hypersensitivity Alec James Redwood, Kaija Strautins, Katie White, Abha Chopra, Katherine Konvinse, Shay Leary, Rebecca Pavlos, Simon Mallal, Elizabeth Phillips P162 Specificity and sensitivity of LTT in DRESS: analysis of agreement with the Spanish pharmacovigilance system probability algorithm Rosario Cabañas, Elena Ramirez, Ana María Fiandor, Teresa Bellón P163 The role of interleukin-22 in β-lactam hypersensitivity Andrew Sullivan, Paul Whitaker, Daniel Peckham, B. Kevin Park, Dean J. Naisbitt P164 Vancomycin-specific T cell responses and teicoplanin cross-reactivity Wei Yann Haw, Marta E. Polak, Carolann Mcguire, Michael R. Ardern-Jones Poster walk 19: BAT and biomarkers (P165–P173) P165 A combination of early biomarkers useful for the prediction of severe ADRs Yumi Aoyama, Tetsuo Shiohara P166 Basophil activation test in the diagnostic approach of reactions during general anaesthesia Ana Moreira, Susana Cadinha, Patrícia Barreira, Ana Castro Neves, Daniela Malheiro, Sara Correia, J. P. Moreira Da Silva P167 IL-10 can be related to successful desensitization Asli Gelincik, Semra Demir, Fatma Sen, Hamza Ugur Bozbey, Muge Olgac, Derya Unal, Raif Coskun, Bahauddin Colakoglu, Suna Buyuozturk, Esin Çatin-Aktas, Gunnur Deniz P168 Immediate reactions to proton pump inhibitors: value of basophil activation test Maria Salas, Jose Julio Laguna, Esther Barrionuevo, J. Dionicio, Tahia Fernandez, R. Gonzalez-Mendiola, I. Olazabal, Maria Dolores Ruiz, Miguel Blanca, Cristobalina Mayorga, Maria José Torres P169 Improvement of the elevated tryptase criterion to discriminate IgE from non-IgE mediated allergic reactions Gabriel Gastaminza, Alberto Lafuente, Carmen D’Amelio, Amalia Bernad, Olga Vega, Roselle Catherine Madamba, M. Jose Goikoetxea, Marta Ferrer, Jorge Núñez P170 Low expression of Tim-3 could serve as a biomarker for control and diagnose maculopapular exanthema induced by drugs Tahia Diana Fernández, Inmaculada Doña, Francisca Palomares, Rubén Fernández, Maria Salas, Esther Barrionuevo, Maria Isabel Sanchez, Miguel Blanca, Maria José Torres, Cristobalina Mayorga P171 Role of basophil activation test using two different activation markers for the diagnosis of allergy to fluoroquinolones Esther Barrionuevo, Tahía Fernandez, Arturo Ruiz, Adriana Ariza, Maria Salas, Inmaculada Doña, Ana Molina, Miguel Blanca, Maria Jose Torres, Cristobalina Mayorga P172 The importance of basophil activation test in anaphylaxis due to celecoxib Amalia Bernad Alonso, Carmen D’Amelio Garófalo, Olga Vega Matute, Marta Ferrer Puga, María José Goikoetxea Lapresa, Roselle Catherine Yu Madamba, Gabriel Gastaminza Lasarte P173 The role of basophil activation test in the diagnosis of immediate type drug hypersensitivity to betalactam antibiotics Antonia Thinnes, Hans F. Merk, Jens Malte Baron, Martin Leverkus, Galina Balakirski Poster walk 20: TCR recognition, cellular (P174–P183) P174 Characterisation of the effect of co-inhibitory signalling on the activation of drug-derived antigen-specific T-cells Andrew Gibson, Monday Ogese, Lee Faulkner, B. Kevin Park, Dean J. Naisbitt P175 Characterization of drug hapten-specific T cell responses in piperacillin hypersensitive patients Zaid Al-Attar, Fiazia Yaseen, Xiaoli Meng, Rozalind Jenkins, Paul Whitaker, Daniel Peckham, Lee Faulkner, John Farrel, Kevin Park, Dean Naisbitt P176 Characterization of the response of T-cells to telaprevir and its metabolite in normal volunteers Zaid Al-Attar, Khetam Alhilali, Yanni Xue, John Farrell, Lee Faulkner, Kevin Park, Dean Naisbitt P177 Characterization of the T cell receptor signatures of drug-responsive T cells Patricia Illing, Nicole Mifsud, Heidi Fettke, Jeffrey Lai, Rebecca Ho, Patrick Kwan, Anthony Purcell P178 Defining the signals between hepatocytes and immune cells in idiosyncratic drug-induced liver injury (DILI) Monday O. Ogese, Lee Faulkner, B. Kevin Park, Catherine Betts, Dean J. Naisbitt P179 Development of novel chemicals that do not bind to HLA-B*57:01 or activate CD8 + T-cells through modification of the 6-amino cyclopropyl group of abacavir Paul Thomson, John Farrell, Mohammad Alhaidari, Neill Berry, Paul M. O’Neill, B. Kevin Park, Dean J. Naisbitt P180 Generation and characterization of dapsone- and nitroso-dapsone-specific T-cell clones using lymphocytes from healthy volunteers Abdulaziz Alzahrani, Monday O. Ogese, John Farrell, Lee Faulkner, Andrew Gibson, Arun Tailor, B. Kevin Park, Dean J. Naisbitt P181 Identification of benzylpenicillin-hapten peptides responsible for naïve T-cell activation and immunization of allergic patients to penicillin Marie Eliane Azoury, Lucia Fili, Rami Bechara, Noémie Scornet, Cathy Nhim, Richard Weaver, Nancy Claude, Delphine Joseph, Bernard Maillere, Paola Parronchi, Marc Pallardy P182 Massive expansion of clonotypic and polycytotoxic CD8+ T cells in toxic epidermal necrolysis Axel Patrice Villani, Aurore Rozières, Benoît Bensaïd, Mathilde Tardieu, Floriane Albert, Virginie Mutez, Tugba Baysal, Marc Pallardy, Janet Maryanski, Jean-François Nicolas, Osami Kanagawa, Marc Vocanson P183 Pharmaco-immunological synapse of HLA-drug-TCR in SCAR Shuen-Iu Hung Poster walk 21: new in vitro methods, haptens, etc. (P184–P194) P184 Amoxicillin-clavulanate forms distinct multiple haptenic structures on human serum albumin in patients Xiaoli Meng, Arun Tailor, Caroline J. Harrison, Rosalind E. Jenkins, Paul Whitaker, Neil S. French, Dean J. Naisbitt, B. Kevin Park P185 Dendrimeric antigens for studying the influence of penicillin determinants orientation on IgE recognition Maria Isabel Montañez, Cristobalina Mayorga, Francisco Najera, Adriana Ariza, Tahia D. Fernandez, Maria Salas, Angela Martin-Serrano, Miguel Blanca, Ezequiel Perez-Inestrosa, Maria Jose Torres P186 Dendrimeric antigens on solid supports: designed materials for IgE quantification Yolanda Vida, Maria Isabel Montañez, Noemi Molina, Daniel Collado, Francisco Najera, Adriana Ariza, Maria Jose Torres, Cristobalina Mayorga, Ezequiel Perez-Inestrosa P187 Development of a screening assay for drug hypersensitivity using naïve T cells from donors with seven different HLA class I risk alleles Lee Faulkner, Sally Wood, Ana Alfirevic, Munir Pirmohamed, Dean J. Naisbitt, B. Kevin Park P188 Different patterns of recognition of structures derived from amoxicillin by IgE antibodies from patients with immediate hypersensitivity reactions to betalactams Adriana Ariza, Cristobalina Mayorga, María Isabel Montañez, María Salas, Inmaculada Doña, Ángela Martín-Serrano, Ezequiel Pérez-Inestrosa, Dolores Pérez-Sala, Miguel Blanca, Antonio E. Guzmán, María José Torres P189 High-resolution typing of HLA polymorphism and T-cell receptor repertoire for severe adverse drug reactions based on the cost-effective next-generation sequencing approaches Tai-Ming Ko, Yuan-Tsong Chen, Jer-Yuarn Wu P190 Identification and fate of intracellular proteins haptenated by amoxicillin Francisco J. Sánchez-Gómez, Juan M. González-Morena, Yolanda Vida, Ezequiel Pérez-Inestrosa, Miguel Blanca, María J. Torres, Dolores Pérez-Sala P191 In vitro detection of terbinafine protein adducts Arun Tailor, Toru Usui, Yanni Xue, Xiaoli Meng, Dean J. Naisbitt, B. Kevin Park P192 MicroRNAs dysregulation in PBMCs from drug hypersensitivity patients during drug challenge in vitro Alejandra Monroy Arreola, Jesus Agustin Badillo Corona, Silvia Mendez Flores, Judith Dominguez Cherit, Dean J. Naisbitt, Noe Valentin Duran Figueroa, Jose Luis Castrejon Flores P193 NSAIDs-exacerbated cutaneous disease: high throughput gene expression profiling José Antonio Cornejo-García, James Perkins, Natalia Blanca-López, Diana Pérez-Alzate, Raquel Jurado-Escobar, Inmaculada Doña, Gador Bogas, María J. Torres, Gabriela Canto, Miguel Blanca P194 Utility of skin tests in non-immediate reactions to amoxicillin Luis Mario Tubella Marti, Fernando Pineda De La Losa, Francisca Arribas Poves, Jaime Tubella Lopez, Teodora Lopez Santiago
- Full Text
- View/download PDF
15. Accuracy of patient-specific I-131 dosimetry using hybrid whole-body planar-SPECT/CT I-123 and I-131 imaging.
- Author
-
Morphis, Michaella, van Staden, Johan A., du Raan, Hanlie, Ljungberg, Michael, and Sjögreen Gleisner, Katarina
- Subjects
COLLIMATORS ,MEDICAL dosimetry ,ABSORBED dose ,MONTE Carlo method - Abstract
Purpose: This study aimed to assess the accuracy of patient-specific absorbed dose calculations for tumours and organs at risk in radiopharmaceutical therapy planning, utilizing hybrid planar-SPECT/CT imaging. Methods: Three Monte Carlo (MC) simulated digital patient phantoms were created, with time-activity data for mIBG labelled to I-123 (LEHR and ME collimators) and I-131 (HE collimator). The study assessed the accuracy of the mean absorbed doses for I-131-mIBG therapy treatment planning. Multiple planar whole-body (WB) images were simulated (between 1 to 72 h post-injection (p.i)). The geometric-mean image of the anterior and posterior WB images was calculated, with scatter and attenuation corrections applied. Time-activity curves were created for regions of interest over the liver and two tumours (diameters: 3.0 cm and 5.0 cm) in the WB images. A corresponding SPECT study was simulated at 24 h p.i and reconstructed using the OS-EM algorithm, incorporating scatter, attenuation, collimator-detector response, septal scatter and penetration corrections. MC voxel-based absorbed dose rate calculations used two image sets, (i) the activity distribution represented by the SPECT images and (ii) the activity distribution from the SPECT images distributed uniformly within the volume of interest. Mean absorbed doses were calculated considering photon and charged particle emissions, and beta emissions only. True absorbed doses were calculated by MC voxel-based dosimetry of the known activity distributions for reference. Results: Considering photon and charged particle emissions, mean absorbed dose accuracies across all three radionuclide-collimator combinations of 3.8 ± 5.5% and 0.1 ± 0.9% (liver), 5.2 ± 10.0% and 4.3 ± 1.7% (3.0 cm tumour) and 15.0 ± 5.8% and 2.6 ± 0.6% (5.0 cm tumour) were obtained for image set (i) and (ii) respectively. Considering charged particle emissions, accuracies of 2.7 ± 4.1% and 5.7 ± 0.7% (liver), 3.2 ± 10.2% and 9.1 ± 1.7% (3.0 cm tumour) and 13.6 ± 5.7% and 7.0 ± 0.6% (5.0 cm tumour) were obtained for image set (i) and (ii) respectively. Conclusion: The hybrid WB planar-SPECT/CT method proved accurate for I-131-mIBG dosimetry, suggesting its potential for personalized treatment planning. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Two-Dimensional Materials for Highly Efficient and Stable Perovskite Solar Cells.
- Author
-
Shen, Xiangqian, Lin, Xuesong, Peng, Yong, Zhang, Yiqiang, Long, Fei, Han, Qifeng, Wang, Yanbo, and Han, Liyuan
- Subjects
SOLAR cells ,ELECTRONIC band structure ,PEROVSKITE ,BORON nitride ,HETEROJUNCTIONS - Abstract
Highlights: Recent progress on the applications of 2D materials in perovskite solar cells is discussed from the views of bottom interfaces, top interfaces, and electrodes. The roles of van der Waals heterojunction in enhancing the performance of perovskite solar cells are highlighted. The future directions and challenges in development of 2D materials-based perovskite solar cells are provided. Perovskite solar cells (PSCs) offer low costs and high power conversion efficiency. However, the lack of long-term stability, primarily stemming from the interfacial defects and the susceptible metal electrodes, hinders their practical application. In the past few years, two-dimensional (2D) materials (e.g., graphene and its derivatives, transitional metal dichalcogenides, MXenes, and black phosphorus) have been identified as a promising solution to solving these problems because of their dangling bond-free surfaces, layer-dependent electronic band structures, tunable functional groups, and inherent compactness. Here, recent progress of 2D material toward efficient and stable PSCs is summarized, including its role as both interface materials and electrodes. We discuss their beneficial effects on perovskite growth, energy level alignment, defect passivation, as well as blocking external stimulus. In particular, the unique properties of 2D materials to form van der Waals heterojunction at the bottom interface are emphasized. Finally, perspectives on the further development of PSCs using 2D materials are provided, such as designing high-quality van der Waals heterojunction, enhancing the uniformity and coverage of 2D nanosheets, and developing new 2D materials-based electrodes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Recent advances in halide perovskite memristors: From materials to applications.
- Author
-
Liu, Sixian, Zeng, Jianmin, Chen, Qilai, and Liu, Gang
- Abstract
With the emergence of the Internet of Things (IoT) and the rapid growth of big data generated by edge devices, there has been a growing need for electronic devices that are capable of processing and transmitting data at low power and high speeds. Traditional Complementary Metal-Oxide-Semiconductor (CMOS) devices are nonvolatile and often limited by their ability for certain IoT applications due to their unnecessary power consumption for data movement in von Neuman architecture-based systems. This has led to a surge in research and development efforts aimed at creating innovative electronic components and systems that can overcome these shortcomings and meet the evolving needs of the information era, which share features such as improved energy efficiency, higher processing speeds, and increased functionality. Memristors are a novel type of electronic device that has the potential to break down the barrier between storage and computing. By storing data and processing information within the same device, memristors can minimize the need for data movement, which allows for faster processing speeds and reduced energy consumption. To further improve the energy efficiency and reliability of memristors, there has been a growing trend toward diversifying the selection of dielectric materials used in memristors. Halide perovskites (HPs) have unique electrical and optical properties, including ion migration, charge trapping effect caused by intrinsic defects, excellent optical absorption efficiency, and high charge mobility, which makes them highly promising in applications of memristors. In this paper, we provide a comprehensive overview of the recent development in resistive switching behaviors of HPs and the underlying mechanisms. Furthermore, we summarize the diverse range of HPs, their respective performance metrics, as well as their applications in various fields. Finally, we critically evaluate the current bottlenecks and possible opportunities in the future research of HP memristors. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Desirable candidates for high-performance lead-free organic–inorganic halide perovskite solar cells.
- Author
-
Sajid, Sajid, Alzahmi, Salem, Salem, Imen Ben, Tabet, Nouar, Haik, Yousef, and Obaidat, Ihab M.
- Subjects
SOLAR cells ,PEROVSKITE ,LEAD ,PRODUCTION sharing contracts (Oil & gas) ,SCIENTIFIC community - Abstract
Perovskite solar cells (PSCs) are currently demonstrating tremendous potential in terms of straightforward processing, a plentiful supply of materials, and easy architectural integration, as well as high power conversion efficiency (PCE). However, the elemental composition of the widely utilized organic–inorganic halide perovskites (OIHPs) contains the hazardous lead (Pb). The presence of Pb in the PSCs is problematic because of its toxicity which may slow down or even impede the pace of commercialization. As a backup option, the scientific community has been looking for non-toxic/less-toxic elements that can replace Pb in OIHPs. Despite not yet matching the impressive results of Pb-containing OIHPs, the community is paying close attention to Pb-free materials and has seen some encouraging findings. This review evaluates the Pb-replacement with suitable elements and scrutinizes the desirable optoelectronic features of such elements in OIHPs. The fundamental features of Pb-free OIHPs together with their photovoltaic performance in the PSCs are evaluated in details. Finally, we sum up the current challenges and potential opportunities for the Pb-free OIHPs and their devices. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Digitale Kunst.
- Author
-
Weibel, Peter
- Abstract
Copyright of Informatik Spektrum is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2021
- Full Text
- View/download PDF
20. Utility of ultrasound in managing acute medical conditions in space: a scoping review.
- Author
-
Parsa, Asachi, Ghadi, Ghanem, Jason, Burton, Haig, Aintablian, and Alan, Chiem
- Subjects
VENOUS thrombosis ,ULTRASONIC imaging ,EMERGENCY management ,OPHTHALMOLOGIC emergencies ,DECOMPRESSION sickness ,DOPPLER ultrasonography - Abstract
Background: In long-distance spaceflight, the challenges of communication delays and the impracticality of rapid evacuation necessitate the management of medical emergencies by onboard physicians. Consequently, these physicians must be proficient in tools, such as ultrasound, which has proven itself a strong diagnostic imaging tool in space. Yet, there remains a notable gap in the discourse surrounding its efficacy in handling acute medical scenarios. This scoping review aims to present an updated analysis of the evidence supporting the role of ultrasound in diagnosing acute conditions within microgravity environments. Methods: A systematic search was executed across three bibliographic databases: PubMed, EMBASE (Embase.com), and the Web of Science Core Collection. We considered articles published up to February 25, 2023, that highlighted the application of ultrasound in diagnosing acute medical conditions in either microgravity or microgravity-simulated settings. Exclusions were made for review papers, abstracts, and in-vitro studies. Results: After removing duplicates, and filtering papers by pre-determined criteria, a total of 15 articles were identified that discuss the potential use of ultrasound in managing acute medical conditions in space. The publication date of these studies ranged from 1999 to 2020. A relatively similar proportion of these studies were conducted either on the International Space Station or in parabolic flight, with one performed in supine positioning to simulate weightlessness. The included studies discuss acute pathologies, such as abdominal emergencies, decompression sickness, deep venous thrombosis, acute lung pathologies, sinusitis, musculoskeletal trauma, genitourinary emergencies, and ocular emergencies. Conclusions: While ultrasound has shown promise in addressing various acute conditions, significant knowledge gaps remain, especially in gastrointestinal, cardiac, vascular, and reproductive emergencies. As we venture further into space, expanding our medical expertise becomes vital to ensure astronaut safety and mission success. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
21. Patient and Clinician Satisfaction in Teledermatology: Key Factors for Successful Implementation.
- Author
-
Li, Yiwen, Pulminskas, Anna, Collins, Olivia, de la Feld, Salma, and Yeung, Howa
- Published
- 2023
- Full Text
- View/download PDF
22. The Safety and Accuracy of Drug Patch Testing in Delayed Hypersensitivity Reactions.
- Author
-
Saff, Rebecca R. and Waldron, Jamie L.
- Published
- 2023
- Full Text
- View/download PDF
23. Circulating miRNAs drive personalized medicine based on subgroup classification in myasthenia gravis patients.
- Author
-
Huang, Xiaoyu, Zhang, Zhouao, Wang, Yingying, Xu, Mingming, Du, Xue, and Zhang, Yong
- Subjects
MICRORNA ,NON-coding RNA ,NEUROMUSCULAR diseases ,GENE expression ,INDIVIDUALIZED medicine ,AUTOIMMUNE diseases ,MYASTHENIA gravis - Abstract
Myasthenia gravis (MG) is a classic autoimmune neuromuscular disease with strong clinical heterogeneity. The concept of subgroup classification was proposed to guide the precise treatment of MG. Subgroups based on serum antibodies and clinical features include ocular MG, early-onset MG with AchR antibodies, late-onset MG with AchR antibodies, thymoma-associated MG, MuSK-associated MG, LRP4-associated MG, and seronegative MG. However, reliable objective biomarkers are still needed to reflect the individualized response to therapy. MicroRNAs (miRNAs) are small non-coding RNA molecules which can specifically bind to target genes and regulate gene expression at the post-transcriptional level, and then influence celluar biological processes. MiRNAs play an important role in the pathogenesis of autoimmune diseases, including MG. Several studies on circulating miRNAs in MG have been reported. However, there is rare systematic review to summarize the differences of these miRNAs in different subgroups of MG. Here, we summarize the potential role of circulating miRNAs in different subgroups of MG to promote personalized medicine. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
24. Development of lung cancer risk prediction models based on F-18 FDG PET images.
- Author
-
Choi, Kaeum, Park, Jae Seok, Kwon, Yong Shik, Park, Sun Hyo, Kim, Hyun Jung, Noh, Hyunju, Won, Kyoung Sook, Song, Bong-Il, and Kim, Hae Won
- Abstract
Objective: We aimed to evaluate whether the degree of F-18 fluorodeoxyglucose (FDG) uptake in the lungs is associated with an increased risk of lung cancer and to develop lung cancer risk prediction models using metabolic parameters on F-18 FDG positron emission tomography (PET). Methods: We retrospectively included 795 healthy individuals who underwent F-18 FDG PET/CT scans for a health check-up. Individuals who developed lung cancer within 5 years of the PET/CT scan were classified into the lung cancer group (n = 136); those who did not were classified into the control group (n = 659). The healthy individuals were then randomly assigned to either the training (n = 585) or validation sets (n = 210). Clinical factors including age, sex, body mass index (BMI), and smoking history were collected. The standardized uptake value ratio (SUVR) and metabolic heterogeneity (MH) index were obtained for the bilateral lungs. Logistic regression models including clinical factors, SUVR, and MH index were generated to quantify the probability of lung cancer development using a training set. The prediction models were validated using a validation set. Results: The lung SUVR and lung MH index in the lung cancer group were significantly higher than in the control group (p < 0.001 and p < 0.001, respectively). In the combined prediction model 1, age, sex, BMI, smoking history, and lung SUVR were significantly associated with lung cancer development (age: OR 1.07, p < 0.001; male: OR 2.08, p = 0.015; BMI: OR 0.93, p = 0.057; current or past smoker: OR 5.60, p < 0.001; lung SUVR: OR 1.13, p < 0.001). In the combined prediction model 2, age, sex, BMI, smoking history, and lung MH index showed a significant association with lung cancer development (age: OR 1.06, p < 0.001; male: OR 1.87, p = 0.045; BMI: OR 0.93, p = 0.010; current or past smoker: OR 4.78, p < 0.001; lung MH index: OR 1.33, p < 0.001). In the validation data, combined prediction models 1 and 2 exhibited very good discrimination [area under the receiver operator curve (AUC): 0.867 and 0.901, respectively]. Conclusions: The metabolic parameters on F-18 FDG PET are related to an increased risk of lung cancer. Metabolic parameters can be used as biomarkers to provide information independent of the clinical parameters, related to lung cancer risk. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
25. Propylamine hydrobromide passivated tin-based perovskites to efficient solar cells.
- Author
-
Li, Xiaomeng, Jia, Pengcheng, Meng, Fanwen, Zhang, Xingyu, Tang, Yang, Song, Bo, Gao, Chang, Qin, Liang, Teng, Feng, and Hou, Yanbing
- Abstract
The development of tin-based devices with low toxicity is critical for the commercial viability of perovskite solar cells. However, because tin halide is a stronger Lewis acid, its crystallization rate is extremely fast, resulting in the formation of numerous defects that affect the device performance of tin-based perovskite solar cells. Herein, propylamine hydrobromide (PABr) was added to the perovskite precursor solution as an additive to passivate defects and fabricate more uniform and dense perovskite films. Because propylamine cations are too large to enter the perovskite lattices, they only exist at the grain boundary to passivate surface defects and promote crystal growth in a preferred orientation. The PABr additive raises the average short-circuit current density from 19.45 to 25.47 mA·cm
−2 by reducing carrier recombination induced by defects. Furthermore, the device's long-term illumination stability is improved after optimization, and the hysteresis effect is negligible. The addition of PABr results in a power conversion efficiency of 9.35%. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
26. Use of Epicutaneous Tests in the Study of Drug Allergy.
- Author
-
García-Abujeta, Jose Luis, Iriarte, Pilar, Gonzalo-Garijo, María Angeles, de las Vecillas, Leticia, and Bernaola, Marta
- Published
- 2023
- Full Text
- View/download PDF
27. Optimising the Utility of In Vitro Tests for the Diagnosis of Drug Allergy: Insights from a Clinical Perspective.
- Author
-
Sabaté-Brescó, Marina, Quan, Paola Leonor, and Goikoetxea, María José
- Published
- 2023
- Full Text
- View/download PDF
28. Drug-Induced Kounis Syndrome: Latest Novelties.
- Author
-
Ollo-Morales, Paula, Gutierrez-Niso, Marta, De-la-Viuda-Camino, Elena, Ruiz-de-Galarreta-Beristain, Marina, Osaba-Ruiz-de-Alegria, Ixone, and Martel-Martin, Carlota
- Published
- 2023
- Full Text
- View/download PDF
29. Cytokine profiles in the aqueous humor following brolucizumab administration for exudative age-related macular degeneration.
- Author
-
Terao, Ryo, Obata, Ryo, Okubo, Atsushi, Aoki, Shuichiro, Azuma, Keiko, Ahmed, Tazbir, Inoda, Satoru, Hashimoto, Yuto, Takahashi, Ryota, Yoshida, Hana, Misawa, Manami, Takahashi, Hironori, and Takahashi, Hidenori
- Subjects
MACULAR degeneration ,CELL adhesion molecules ,AQUEOUS humor ,VASCULAR endothelial growth factors ,GRANULOCYTE-colony stimulating factor - Abstract
Purpose: To identify the inflammatory cytokine profile in the aqueous humor (AH) of patients with intraocular inflammation (IOI) after intravitreal administration of brolucizumab (IVBr) for neovascular age-related macular degeneration. Methods: Eight eyes from seven patients with IOI after initial IVBr (IVBrIOI +) were enrolled. Sixteen eyes from 16 patients without IOI after IVBr (IVBrIOI −) and aflibercept (IVA) were used as controls. AH samples were analyzed using a multiplex immunoassay. Results: C–C motif chemokine ligand (CCL)2, C-X-C motif chemokine ligand (CXCL)1, CXCL10, CXCL13, interleukin (IL)-6, IL-8, IL-10, matrix metalloproteinase (MMP)-1, MMP-9, granulocyte colony-stimulating factor (G-CSF), granulocyte–macrophage colony-stimulating factor (GM-CSF), intercellular adhesion molecule (ICAM)-1, E-selectin, and P-selectin levels were significantly higher in IVBrIOI + than in IVBrIOI − and IVA. Vascular endothelial growth factor (VEGF) was significantly lower in IVBrIOI − compared to that in IVBrIOI + and IVA. In the IVBrIOI + group, there were significant correlations between CCL2, CXCL1, IL-6, IL-8, IL-10, G-CSF, GM-CSF, ICAM-1, and E-selectin, which also exhibited significant correlations in the IVBrIOI − group. Conclusion: The number of inflammatory cytokines increases during IOI, which is associated with type IV hypersensitivity and vascular inflammation. Some cytokines exhibit correlations even in non-inflamed eyes, indicating a subclinical response to IVBr. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
30. The patient perspective on vaccine uptake in adults with psoriasis and eczema.
- Author
-
Noe, Megan H., Archila, Marjorie, Barbieri, John S., Goldman, Nathaniel, Lopez, Christina G., Mostaghimi, Arash, Scherer, Aaron M., Tan, Alice J., Perez-Chada, Lourdes M., Asgari, Maryam M., and Gelfand, Joel M.
- Subjects
VACCINATION status ,PATIENTS' attitudes ,ECZEMA ,PSORIASIS ,SKIN diseases - Abstract
Having a chronic disease is one of the most consistent factors associated with vaccine uptake for adults in the general population, but vaccination beliefs and behaviors specific to those with chronic skin diseases have not been explored. The objective of this study was to explore factors associated with vaccine uptake and barriers to vaccination in adults with psoriasis and eczema. Virtual, video-based semi-structured interviews were performed with adults who self-reported a diagnosis of psoriasis or eczema. Interviews explored themes around healthcare decision making, perceived risks/benefits to vaccination, barriers, and vaccine knowledge. Thematic analysis was used to analyze the data. Of 34 study participants, 25 participants (74%) were females and 9 (26%) were males, with a mean age of 50.8 years (SD: 16.4, range: 24–71 yrs). Half of participants (n = 17) had psoriasis, and half (n = 17) had eczema. Participants recognized both personal and societal benefits to vaccines. Common vaccination barriers identified were access to appointments, concerns about side effects, and misinformation. Physicians, friends/family, and media, including internet resources, were health information resources identified by patients. These results summarize the unique patient perspective around vaccine uptake in adults with eczema and psoriasis and represent an important first step in a multi-pronged approach to improve vaccination rates in adults with chronic skin diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
31. Ligand Engineering in Tin-Based Perovskite Solar Cells.
- Author
-
Li, Peizhou, Cao, Xiangrong, Li, Jingrui, Jiao, Bo, Hou, Xun, Hao, Feng, Ning, Zhijun, Bian, Zuqiang, Xi, Jun, Ding, Liming, Wu, Zhaoxin, and Dong, Hua
- Subjects
SOLAR cells ,PEROVSKITE ,HOT carriers ,CRYSTAL orientation ,ENGINEERING ,CHARGE carrier mobility - Abstract
Highlights: Systematic summary of ligand engineering in Sn-based perovskite solar cells at the molecular level (oxidation-suppression), crystal structural level (bulk-defect passivation and crystal orientation optimization), and film level (film stability). The classification and composition of ligand engineering in the review are the same as the actual preparation process, which will help researchers to understand the role of ligands in combination with the actual experiment process. Description of ligands focuses on the function of each functional group; the relevant conclusion can be universal. Perovskite solar cells (PSCs) have attracted aggressive attention in the photovoltaic field in light of the rapid increasing power conversion efficiency. However, their large-scale application and commercialization are limited by the toxicity issue of lead (Pb). Among all the lead-free perovskites, tin (Sn)-based perovskites have shown potential due to their low toxicity, ideal bandgap structure, high carrier mobility, and long hot carrier lifetime. Great progress of Sn-based PSCs has been realized in recent years, and the certified efficiency has now reached over 14%. Nevertheless, this record still falls far behind the theoretical calculations. This is likely due to the uncontrolled nucleation states and pronounced Sn (IV) vacancies. With insights into the methodologies resolving both issues, ligand engineering-assisted perovskite film fabrication dictates the state-of-the-art Sn-based PSCs. Herein, we summarize the role of ligand engineering during each state of film fabrication, ranging from the starting precursors to the ending fabricated bulks. The incorporation of ligands to suppress Sn
2+ oxidation, passivate bulk defects, optimize crystal orientation, and improve stability is discussed, respectively. Finally, the remained challenges and perspectives toward advancing the performance of Sn-based PSCs are presented. We expect this review can draw a clear roadmap to facilitate Sn-based PSCs via ligand engineering. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
32. Gründe für allergologische Diagnostik und deren Ergebnisse im Kontext von COVID-19-Vakzinierungen: 2-jährige Erfahrung eines Allergiezentrums in Nordrhein-Westfalen.
- Author
-
Leonidou Floruß, Eleni, Demidova, Anastasiia, Hofmann, Silke C., and Balakirski, Galina
- Abstract
Copyright of Die Dermatologie is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2023
- Full Text
- View/download PDF
33. Why mild contrast medium-induced reactions are sometimes over-treated and moderate/severe reactions of internal organs are undertreated: a summary based on RadioComics.
- Author
-
Lombardo, Paolo, Nairz, Knud, and Boehm, Ingrid
- Subjects
PATIENT preferences ,DIAGNOSTIC imaging ,PREMEDICATION ,RADIOLOGISTS - Abstract
This article discusses the treatment of contrast-medium induced adverse reactions in patients undergoing medical imaging procedures. It highlights the discrepancy in the level of premedication given to patients with mild cutaneous reactions compared to those with moderate to severe systemic reactions. The authors speculate that visually apparent allergic symptoms are more likely to trigger a response and pre-treatment, while non-immediate symptoms, such as kidney damage, may go unnoticed. The article suggests that radiologists should adjust their prophylactic regimen based on patients' preferences and underlying diseases. The use of RadioComics is also mentioned as a way to simplify complex issues. [Extracted from the article]
- Published
- 2023
- Full Text
- View/download PDF
34. Allergic and other adverse reactions to drugs used in anesthesia and surgery.
- Author
-
Baldo, Brian A.
- Subjects
DRUG side effects ,ANTIFIBRINOLYTIC agents ,VASCULAR surgery ,HLA histocompatibility antigens ,DRUG therapy ,SUGAMMADEX - Abstract
The list of drugs patients may be exposed to during the perioperative and postoperative periods is potentially extensive. It includes induction agents, neuromuscular blocking drugs (NMBDs), opioids, antibiotics, sugammadex, colloids, local anesthetics, polypeptides, antifibrinolytic agents, heparin and related anticoagulants, blue dyes, chlorhexidine, and a range of other agents depending on several factors related to individual patients' clinical condition and progress in the postoperative recovery period. To avoid poor or ultrarapid metabolizers to a particular drug (for example tramadol and codeine) or possible adverse drug reactions (ADRs), some drugs may need to be avoided during or after surgery. This will be the case for patients with a history of anaphylaxis or other adverse events/intolerances to a known drug. Other drugs may be ceased for a period before surgery, e.g., anticoagulants that increase the chance of bleeding; diuretics for patients with acute renal failure; antihypertensives relative to kidney injury after major vascular surgery; and serotonergic drugs that together with some opioids may rarely induce serotonin toxicity. Studies of germline variations shown by genotyping and phenotyping to identify a predisposition of genetic factors to ADRs offer an increasingly important approach to individualize drug therapy. Studies of associations of human leukocyte antigen (HLA) genes with some serious delayed immune-mediated reactions are ongoing and variations of drug-metabolizing cytochrome CYP450 enzymes, P-glycoprotein, and catechol-O-methyltransferase show promise for the assessment of ADRs and non-responses to drugs, particularly opioids and other analgesics. Surveys of ADRs from an increasing number of institutions often cover small numbers of patients, are retrospective in nature, fail to clearly identify culprit drugs, and do not adequately distinguish immune-mediated from non-immune-mediated anaphylactoid reactions. From the many surveys undertaken, the large list of agents identified during and after anesthesia and surgery are examined for their ADR involvement. Drugs are classified into those most often involved, (NMBD and antibiotics); drugs that are becoming more frequently implicated, namely antibiotics (particularly teicoplanin), and blue dyes; those becoming less frequently involved; and drugs more rarely involved in perioperative, and postoperative adverse reactions but still important and necessary to keep in mind for the occasional potential sensitive patient. Clinicians should be aware of the similarities between drug-induced true allergic type I IgE/FcεRI- and pseudoallergic MRGPRX2-mediated ADRs, the clinical features of each, and their distinguishing characteristics. Procedures for identifying MRGPRX2 agonists and diagnosing and distinguishing pseudoallergic from allergic reaction mechanisms are discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
35. Advances and Applications of Cellulose Bio-Composites in Biodegradable Materials.
- Author
-
Chen, Zhen, Aziz, Tariq, Sun, Hongyue, Ullah, Asmat, Ali, Amjad, Cheng, Li, Ullah, Roh, and Khan, Farman Ullah
- Subjects
CELLULOSE ,HYDROCOLLOIDS ,BIODEGRADABLE materials ,BIOPOLYMERS ,ORGANIC solvents ,THERMAL conductivity ,CORROSION resistance - Abstract
Cellulose is a natural polymer that has a lot of potentials. Cellulose gained more interest owing to its renewability, non-toxicity, economic value, biodegradability, high mechanical properties, high surface area, and biocompatibility. New sources, new isolation processes, and new treatments are currently under development to satisfy the increasing demand for producing new types of bio-based materials on an industrial scale. This article discusses the fundamentals and latest breakthroughs in cellulose biopolymer materials used in the fabrication of composite films owing to the cellulose forming films. Bio-polymers are finding wide applications due to their intrinsic properties such as low density, low thermal conductivity, corrosion resistance, and ease of manufacturing complex shapes. Cellulose possesses a highly crystallized structure, hence it is insoluble in typical organic solvents. Environmental restrictions are increasingly stringent, which is a key element leading to the growth of studies on this subject. These hydrocolloids have been modified by taking advantage of their valuable features; the mechanical strength and water resistance of cellulose make it being used as a thickener for large-scale applications such as cellulose composite films can extend the shelf life of a product while maintaining its biodegradability. New materials with high values are a hot topic for future research with commercial interest. These composite film potentials are contributing to the bio-economy. Here, the emphasis on the potential application of bio-composites of cellulose in various industries has been discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
36. What should be considered during epicutaneous patch testing?
- Author
-
Brans, Richard and Mahler, Vera
- Published
- 2023
- Full Text
- View/download PDF
37. Revisiting the Definition of Anaphylaxis.
- Author
-
Hammond, Catherine
- Abstract
Purpose of Review: Anaphylaxis is a common phenomenon that has been studied for many decades. Despite this, there is still disagreement among organizations regarding the precise definition for anaphylaxis. This article discusses the difference between the proposed definitions of anaphylaxis. Furthermore, the most up-to-date literature on specific subtypes of anaphylaxis is reviewed, and implications for clinical practice are discussed. Recent Findings: Recent literature on various subtypes of anaphylaxis has been conducted. This has helped clarify guidelines for conditions such as allergy to radiocontrast media, idiopathic anaphylaxis, and food-dependent exercise-induced anaphylaxis. Recent literature has also studied available biomarkers for anaphylaxis and the cost-effectiveness of current standard-of-care prescription of epinephrine autoinjectors. Summary: Anaphylaxis is an increasingly more frequent phenomenon and remains a hot topic in current research. Much progress has been made in clarifying the definition of anaphylaxis and differentiating between subtypes, but more research is needed to identify a readily available biomarker for anaphylaxis and identify the standard of care for various subtypes of anaphylaxis. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
38. Effect of cardiovascular stents' materials on percutaneous transluminal coronary angioplasty: A biomechanical finite element analysis.
- Author
-
Deng, Chao-Dong, Zhang, Li-Xian, Wang, Shao-Li, Zhang, Yi-Lin, and Yan, Ting-Ting
- Published
- 2023
- Full Text
- View/download PDF
39. Ionic Liquid Assisted Imprint for Efficient and Stable Quasi-2D Perovskite Solar Cells with Controlled Phase Distribution.
- Author
-
Peng, Haibin, Li, Dengxue, Li, Zongcai, Xing, Zhi, Hu, Xiaotian, Hu, Ting, and Chen, Yiwang
- Subjects
SOLAR cells ,PHOTOVOLTAIC power systems ,PEROVSKITE ,IONIC liquids ,RECRYSTALLIZATION (Metallurgy) ,GRAIN size ,CHARGE transfer - Abstract
Highlights: The strategy of imprint assisted with methylamine acetate effectively ameliorates the morphology of the film, optimize the internal phase distribution, and enhance the charge transfer of the perovskite film. The combination of imprinting with additive engineering improves the phase distribution within quasi-2D perovskite and promote the carrier transport, resulting in a power conversion efficiency of 18.96% with specific good reproducibility. Although two-dimensional perovskite devices are highly stable, they also lead to a number of challenges. For instance, the introduction of large organic amines makes crystallization process complicated, causing problems such as generally small grain size and blocked charge transfer. In this work, imprint assisted with methylamine acetate were used to improve the morphology of the film, optimize the internal phase distribution, and enhance the charge transfer of the perovskite film. Specifically, imprint promoted the dispersion of spacer cations in the recrystallization process with the assistance of methylamine acetate, thus inhibited the formation of low-n phase induced by the aggregation of spacer cations and facilitated the formation of 3D-like phase. In this case, the corresponding quasi-2D perovskite solar cells delivered improved efficiency and exhibited superior stability. Our work provides an effective strategy to obtain uniform phase distribution for quasi-2D perovskite. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
40. Diagnostik von Arzneimittelallergien und -intoleranzen.
- Author
-
Walter, Christian and Neustädter, Irena
- Abstract
Copyright of Monatsschrift Kinderheilkunde is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2023
- Full Text
- View/download PDF
41. Highly efficient perovskite solar cells by building 2D/3D perovskite heterojuction in situ for interfacial passivation and energy level adjustment.
- Author
-
Huang, Yaoyao, Yuan, Zhangyu, Yang, Jia, Yin, Shungao, Liang, Aihui, Xie, Gang, Feng, Chuizheng, Zhou, Zhisheng, Xue, Qifan, Pan, Yang, Huang, Fei, and Chen, Yiwang
- Abstract
Passivating the interfacial defects and reducing the interfacial non-radiative recombination losses are the keys to improving the photovoltaic performance of three-dimensional (3D) perovskite solar cells (PVSCs). Stacking two dimensional (2D) perovskites on 3D perovskite is a promising method for interfacial treatment that improves the stability and efficiency of PVSCs. Herein, we developed conjugated fluorinated benzimidazolium cation (FBIm
+ ) which can be inserted between 3D perovskite and hole-transporting layer (HTL) to form 2D perovskite in situ. The 2D single crystal structures of (FBIm)2 PbI4 and (FBIm)2 PbBr4 were achieved and confirmed by single-crystal X-ray diffraction (XRD), while few single crystals of 2D perovskite based on imidazolium or benzimidazolium anchors have been reported. The 2D perovskite can passivate the interfacial defects, induce better crystallinity and orientation, conduct lower trap density and extend carrier lifetime. Furthermore, the energy level arrangement can be regulated by changing the counterion from iodide to bromide, which can efficiently improve the hole extraction and device performances. As a consequence, the best efficiency of 23.00% for FBImBr-incorporated devices was achieved, while only 20.72% for the control device. Meanwhile, the PVSCs modified by FBImBr displayed excellent environmental stability due to the constructed hydrophobic 2D perovskite layer which can effectively block moisture permeation. This work develops a new path to design novel conjugated organic passivants to form 2D/3D perovskite structures. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
42. Novel and Off-Label Biologic Use in the Management of Hidradenitis Suppurativa, Pyoderma Gangrenosum, Lichen Planus, and Seborrheic Dermatitis: A Narrative Review.
- Author
-
Mital, Rohan, Gray, Ashley, Minta, Abena, Almhana, Farah, Amin, Sabrina, Hydol-Smith, Jourdan, Mallela, Teja, and Kaffenberger, Benjamin H.
- Subjects
HIDRADENITIS suppurativa ,PYODERMA gangrenosum ,LICHEN planus ,OFF-label use (Drugs) ,SEBORRHEIC dermatitis ,TUMOR necrosis factors - Abstract
With advances in drug development and our understanding of the pathophysiology of skin disease, biologic medications have emerged as powerful management tools for dermatologists. While biologics have most often been used in the management of psoriasis, they are being used off-label for the management of a variety of other immune-mediated skin diseases with overlapping molecular targets. This narrative review focuses on the novel and off-label use of biologic medications for the management of hidradenitis suppurativa (HS), pyoderma gangrenosum (PG), lichen planus (LP), and seborrheic dermatitis (SD). Review of the literature revealed that IL-17, IL-23, and tumor necrosis factor (TNF) inhibitors were being used across a variety of immune-mediated skin pathologies with variable efficacy, among other targeted biologics. While biologics were generally safe in the treatment of primary immune-mediated skin disorders, paradoxical disease eruptions were noted with biologic use and were theorized to occur owing to immune dysregulation and cytokine imbalance. While numerous case reports show promise for the use of biologics in immune-mediated skin pathologies, the variable efficacy and safety reported warrants more thorough investigations of the role of these targeted medications in comprehensive disease management. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
43. Functional polymer passivating FA0.85PEA0.15SnI3 for efficient and stable lead-free perovskite solar cells.
- Author
-
Xu, Wenzhan, Gao, Yu, He, Miao, Chen, Shuyan, Fu, Hongyan, and Wei, Guodan
- Subjects
PEROVSKITE ,SOLAR cells ,THIN films ,ENERGY conversion ,OPTOELECTRONIC devices - Abstract
Due to their excellent advantages such as low toxicity, superior optoelectronic properties, low-temperature fabrication, and cost-effectiveness, Sn-based perovskites have become the most promising alternatives for high performance lead-free perovskite solar cells. However, the character of Sn
2+ is easily oxidized to Sn4+ , causing unnecessary p-type self-doping and high leakage current. More seriously, trap-induced non-radiative recombination from rapid crystallization causes into large energy loss with a low open circuit voltage. Therefore, the Sn-based solar cells have efficiency far behind the Pb-based solar cells. Herein, the polymer poly(ethylene glycol) diacrylate (PEGDA) is used to control crystal growth and passivate the defects in FA0.85 PEA0.15 SnI3 thin film. This Sn-perovskite layer shows compact crystal with large grain size and reduced defects. Optimized perovskite thin film is further processed to fabricate the inverted solar cell with device structure of ITO (indium tin oxide)/PEDOT:PSS (Poly(3,4-ethylenedioxythiophene)/poly(styrenesulfonate))/FA0.85 PEA0.15 SnI3 /ICBA (indene-C60 bisadduct)/BCP (bathocuproine)/Ag, which shows the power conversion efficiency (PCE) of 11.45% with voltage of 0.82 V. Moreover, corresponding perovskite solar cells exhibit an enhanced stability due to PEGDA induced compressive strain in perovskite. This work could shed light on one of successful attempts to improve Sn-based solar cell efficiency for sustainable energy conversion. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
44. Recent progress in perovskite solar cells: material science.
- Author
-
Shao, Jiang-Yang, Li, Dongmei, Shi, Jiangjian, Ma, Chuang, Wang, Yousheng, Liu, Xiaomin, Jiang, Xianyuan, Hao, Mengmeng, Zhang, Luozheng, Liu, Chang, Jiang, Yiting, Wang, Zhenhan, Zhong, Yu-Wu, Liu, Shengzhong Frank, Mai, Yaohua, Liu, Yongsheng, Zhao, Yixin, Ning, Zhijun, Wang, Lianzhou, and Xu, Baomin
- Abstract
Perovskite solar cells represent a promising third-generation photovoltaic technology with low fabrication cost and high power conversion efficiency. In light of the rapid development of perovskite materials and devices, a systematic survey on the latest advancements covering a broad range of related work is urgently needed. This review summarizes the recent major advances in the research of perovskite solar cells from a material science perspective. The discussed topics include the devices based on different type of perovskites (organic-inorganic hybrid, all-inorganic, and lead-free perovskite and perovskite quantum dots), the properties of perovskite defects, different type of charge transport materials (organic, polymeric, and inorganic hole transport materials and inorganic and organic electron transport materials), counter electrodes, and interfacial materials used to improve the efficiency and stability of devices. Most discussions focus on the key progresses reported within the recent five years. Meanwhile, the major issues limiting the production of perovskite solar cells and the prospects for the future development of related materials are discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
45. Two-dimensional halide perovskites: A review on their orientations.
- Author
-
Lv, Taoyuze, Liang, Yuhang, Li, Feng, Yang, Xudong, Huang, Jun, and Zheng, Rongkun
- Abstract
Two-dimensional halide perovskites, emerging materials with quantum well structures, demonstrate excellent physical properties, such as easily tunable band structures, hot-phonon bottleneck, photo-induced phase segregation, and spin-orbit coupling, and therefore hold great potential for various optoelectronic devices. Interestingly, this class of perovskite materials also possesses a unique anisotropic feature, and their orientations can highly affect their charge carrier behaviors and other related properties. Therefore, effectively controlling the orientation of two-dimensional halide perovskites is of vital importance. So far, various methods, on the basis of different mechanisms have been developed to modulate the orientation, particularly the out-of-plane orientation. Herein, we summarize recent advances in these strategies for enabling the out-of-plane orientation for two-dimensional perovskites. We then systematically review the possible principles for tunning the orientation, followed by an overview of the remaining problems, particularly the microscopic mechanisms behind these modulation methods and their influences, and the future perspectives. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
46. A study of the regional differences in propacetamol-related adverse events using VigiBase data of the World Health Organization.
- Author
-
Jeong, Han Eol, Bea, Sungho, Yoon, Dongwon, Jung, Juhong, Park, Seung-Mok, Jeon, Juhee, Ye, Young-Min, Lee, Jae-Hyun, and Shin, Ju-Young
- Subjects
REGIONAL differences ,CONTACT dermatitis ,WORLD health ,REGIONAL disparities ,STEVENS-Johnson Syndrome - Abstract
Upon withdrawal of propacetamol, an injectable formulation of the paracetamol prodrug, in Europe due to safety concerns, South Korea's regulatory body requested a post-marketing surveillance study exploring its safety profile. We characterized regional disparities in adverse events (AE) associated with propacetamol between Asia and Europe using the World Health Organization's pharmacovigilance database, VigiBase. We performed disproportionality analyses using reporting odds ratios (rOR) and information component (IC) to determine whether five AEs (anaphylaxis, Stevens–Johnson syndrome, thrombosis, contact dermatitis/eczema, injection site reaction [ISR]) were associated with propacetamol versus non-propacetamol injectable antipyretics in Asia and Europe, separately. In Asia, there was a high reporting ratio of propacetamol-related ISR (rOR 5.72, 95% CI 5.19–6.31; IC
025 1.27), satisfying the signal criteria; there were no reports of thrombosis and contact dermatitis/eczema. Two signals were identified in Europe, with higher reporting ratios for thrombosis (rOR 7.45, 95% CI 5.19–10.71; IC025 1.92) and contact dermatitis/eczema (rOR 16.73, 95% CI 12.48–22.42; IC025 2.85). Reporting ratios of propacetamol-related anaphylaxis were low for Asia and Europe. While signals were found for thrombosis and contact dermatitis/eczema in Europe, these were not detected in Asia. These findings suggest potential ethnic differences in propacetamol-related AEs between Asia and Europe, which could serve as supportive data for future decision-making. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
47. An In-Situ Formed Tunneling Layer Enriches the Options of Anode for Efficient and Stable Regular Perovskite Solar Cells.
- Author
-
Lin, Xuesong, Wang, Yanbo, Su, Hongzhen, Qin, Zhenzhen, Zhang, Ziyang, Chen, Mengjiong, Yang, Min, Zhao, Yan, Liu, Xiao, Shen, Xiangqian, and Han, Liyuan
- Subjects
SOLAR cells ,SILVER iodide ,PEROVSKITE ,ANODES ,SCHOTTKY barrier ,TUNNEL design & construction ,PRODUCTION sharing contracts (Oil & gas) - Abstract
Highlights: It is first disclosed that the key to the efficient regular Ag-perovskite solar cells (PSCs) is a tunneling layer (silver iodide, AgI) that is in situ formed by the natural reaction between Ag and the migrated iodide. Based on the discovery, an ultrathin and uniform tunneling layer can be deposited on the fragile perovskite/charge transport layer to enrich the options of electrodes for efficient and stable regular PSCs. Perovskite solar cells (PSCs) are taking steps to commercialization. However, the halogen-reactive anode with high cost becomes a stumbling block. Here, the halogen migration in PSCs is utilized to in situ generate a uniform tunneling layer between the hole transport materials and anodes, which enriches the options of anodes by breaking the Schottky barrier, enabling the regular PSCs with both high efficiency and stability. Specifically, the regular PSC that uses silver iodide as the tunneling layer and copper as the anode obtains a champion power conversion efficiency of 23.24% (certified 22.74%) with an aperture area of 1.04 cm
2 . The devices are stable, maintaining 98.6% of the initial efficiency after 500 h of operation at the maximum power point with continuous 1 sun illumination. PSCs with different tunneling layers and anodes are fabricated, which confirm the generality of the strategy. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
48. Hypersensitivity Reactions to Monoclonal Antibodies: New Approaches.
- Author
-
Gelis, Sonia, Verdesoto, Jenny-Tatiana, Pascal, Mariona, and Muñoz-Cano, Rosa Maria
- Published
- 2022
- Full Text
- View/download PDF
49. Recent progress in perovskite solar cells: from device to commercialization.
- Author
-
Luo, Xinhui, Lin, Xuesong, Gao, Feng, Zhao, Yang, Li, Xiaodong, Zhan, Liqing, Qiu, Zexiong, Wang, Jin, Chen, Cong, Meng, Lei, Gao, Xiaofeng, Zhang, Yu, Huang, Zijian, Fan, Rundong, Liu, Huifen, Chen, Yanrun, Ren, Xiaoxue, Tang, Jiahong, Chen, Chun-Hao, and Yang, Dong
- Abstract
Perovskite solar cells (PSCs) are undergoing rapid development and the power conversion efficiency reaches 25.7% which attracts increasing attention on their commercialization recently. In this review, we summarized the recent progress of PSCs based on device structures, perovskite-based tandem cells, large-area modules, stability, applications and industrialization. Last, the challenges and perspectives are discussed, aiming at providing a thrust for the commercialization of PSCs in the near future. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
50. Case series of chronic spontaneous urticaria following COVID-19 vaccines: an unusual skin manifestation.
- Author
-
Ben-Fredj, Nadia, Chahed, Ferdaous, Ben-Fadhel, Najah, Mansour, Khadija, Ben-Romdhane, Haifa, Mabrouk, Randa Said El, Chadli, Zohra, Ghedira, Donia, Belhadjali, Hichem, Chaabane, Amel, and Aouam, Karim
- Subjects
SKIN tests ,IMMUNOGLOBULINS ,COVID-19 vaccines ,CUTANEOUS manifestations of general diseases ,RETROSPECTIVE studies ,ANGIONEUROTIC edema ,ANTIHISTAMINES ,URTICARIA ,CASE studies - Abstract
Background: Urticaria following the COVID-19 vaccine was rarely reported and had a short self-limited resolution. However, there has been relatively little literature published on CSU induced by COVID-19 vaccines. Purpose: We describe a case series of patients who experienced CSU after SARS-CoV-2 vaccination. Methods: A retrospective case series of 10 patients referred to the Department of Clinical Pharmacology of the University of Monastir (January 2021–January 2022) and included for evaluation of urticaria after COVID-19 vaccination. Results: The median age was 31 years and patients were mostly female. Atopy was presented in 3 patients and urticaria was accompanied by angioedema in 6 patients. The median time interval between vaccination and the onset of urticaria was 28.5 h. The offended dose was the first one in 8 patients. The resolution of the eruption was observed at least 2 months later, despite the regular use of a full dose of antihistamine in nine patients. Polynuclear leucocytosis was identified in 5 patients. Anti-TPOAb was positive in one patient after receiving the BNT162b2 vaccine. Total serum IgE was elevated in 4 patients. Skin tests for the suspected vaccine as well as the vaccine excipient were negative. Conclusion: We add to the medical literature ten new cases of chronic spontaneous urticarial reactions following COVID-19 vaccines uncontrolled with high-dose first-generation H1 antihistamines. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.